Autopsy report · NCT01728116
Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese
Cause of deathSlow enrollment
“Higher than anticipated rate of Hepatic abscess (N=7)”
Life of this trial
- Registered 1 month before it started.
- Ran for about 3 years 2 months before it stopped.
- 325 participants enrolled.
- Results were posted on the registry 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Morphic Medical Inc.
- Sponsor type
- Industry
- Conditions
- Type 2 Diabetes; Obesity
- Interventions
- EndoBarrier; Sham Procedure
- Participants
- 325
- Sites
- 25
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.